Several studies have reported the under-representation of women in clinical trials, thereby challenging the external validity of the benefit/risk assessments of launched drugs. Our aim was to determine the extent to which women have been included in clinical trials used for drug registration and to analyse the fraction of women participating in phases I, II and III.
Gender differences in clinical registration trials: is there a real problem?
CHDR
Labots G, Jones A, de Visser SJ, Rissmann R, Burggraaf J
